Search details
1.
Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
Breast Cancer Res
; 26(1): 84, 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38802897
2.
Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy.
Pathobiology
; 90(6): 400-408, 2023.
Article
in English
| MEDLINE | ID: mdl-37463569
3.
Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
BMC Cancer
; 21(1): 229, 2021 Mar 06.
Article
in English
| MEDLINE | ID: mdl-33676446
4.
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium.
Urol Int
; 96(1): 5-13, 2016.
Article
in English
| MEDLINE | ID: mdl-26068576
5.
Multidisciplinary care in patients with prostate cancer: room for improvement.
Support Care Cancer
; 21(8): 2327-33, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23529667
6.
[Principle and practice of clinical phase III studies]. / Planung und Durchführung klinischer Phase-III-Studien.
Onkologie
; 31 Suppl 2: 53-7, 2008.
Article
in German
| MEDLINE | ID: mdl-18487870
7.
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry.
Clin Genitourin Cancer
; 2017 Aug 24.
Article
in English
| MEDLINE | ID: mdl-28958629
8.
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.
Cancer Chemother Pharmacol
; 57(4): 533-9, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16052341
9.
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer.
Breast
; 15(1): 64-8, 2006 Feb.
Article
in English
| MEDLINE | ID: mdl-15998587
10.
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
Mol Oncol
; 10(5): 693-703, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26809501
11.
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.
J Clin Oncol
; 21(1): 66-8, 2003 Jan 01.
Article
in English
| MEDLINE | ID: mdl-12506172
12.
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
J Clin Oncol
; 20(7): 1759-66, 2002 Apr 01.
Article
in English
| MEDLINE | ID: mdl-11919232
13.
Focus on cancer prevention.
Trends Mol Med
; 8(7): 315-7, 2002 Jul.
Article
in English
| MEDLINE | ID: mdl-12114106
14.
Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy.
Oncol Res Treat
; 38(11): 560-9, 2015.
Article
in English
| MEDLINE | ID: mdl-26599269
15.
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.
Cancer Gene Ther
; 9(3): 289-95, 2002 Mar.
Article
in English
| MEDLINE | ID: mdl-11896446
16.
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.
Oncotarget
; 5(3): 764-74, 2014 Feb 15.
Article
in English
| MEDLINE | ID: mdl-24519926
17.
Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.
Eur J Cancer
; 42(15): 2660-1, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-16934972
18.
The antihormonal preventive therapy of breast cancer and prostate cancer.
Horm Mol Biol Clin Investig
; 5(2): 117-23, 2011 Mar 01.
Article
in English
| MEDLINE | ID: mdl-25961247
19.
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer.
Onkologie
; 30(7): 355-60, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17596743
20.
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.
Br J Haematol
; 131(3): 329-37, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16225652